Institutional investors hold a majority ownership of MRK through the 75.71% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE SECURITIES (USA) L... Bought 7.9 Million shares of Merck
MASSACHUSETTS FINANCIAL SERVICES... Bought 7.4 Million shares of Merck
WELLINGTON MANAGEMENT CO. LLP Bought 6.7 Million shares of Merck